Skip to main content
. 2014 Apr;20(2):242–252. doi: 10.5056/jnm.2014.20.2.242

Table 4.

Total Costs of Irritable Bowel Syndrome

Cost category Subsection Details Any medical service users with IBSa
Frequent usersb
Outpatients
Hospitalization
Total
Total
Costs % Costs % Costs % Costs %
Direct costs (A) 348,670,489 74.2 71,654,254 80.3 420,324,742 75.2 239,224,768 76.1
Medical costs Healthcare servicesa 149,894,403 31.9 70,586,501c 79.1 220,480,903a 39.4 126,921,710 40.4
Pharmacyb 113,621,831 24.2 -c - 113,621,831 20.3 69,231,651 22.0
Non-medical costs Transportation 85,154,256 18.1 1,067,753 1.2 86,222,008 15.4 43,071,407 13.7
Indirect costs (productivity loss) (B) 121,063,582 25.8 17,540,565 19.7 138,604,147 24.8 75,118,030 23.9
Total (A + B) 469,734,070 100.0 89,194,819 100.0 558,928,890 100.0 314,342,799 100.0
a

Healthcare service costs are the sum of National Health Insurance (NHI)-covered cost, beneficiary copayments and NHI-uncovered payments;

b

Pharmacy costs are the sum of pharmaceutical costs for drugs and preparation fees for medications;

c

Pharmacy costs during hospitalization are summed into the costs for healthcare services. IBS, irritable bowel syndrome.

Costs are presented in US dollars (1 USD = 1,047.3 Korean won, 2008).